Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

arglecin

Known as: 6-(3-guanidino-propyl)-3-isobutyl-2-(1H)- pyrazinone 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The invention provides novel substituted 6-arylamino pyridone sulfonamides and 6 arylamino pyrazinone sulfonamides represented by… Expand
Is this relevant?
2008
2008
Akt kinases are attractive targets for small molecule drug discovery because of their key role in tumor cell survival… Expand
Is this relevant?
2008
2008
La presente invention porte sur des derives de pyrazinone representes par la formule (I) dans laquelle R1, R2, R3, R4, R5, R6 et… Expand
Is this relevant?
2007
2007
La presente invention concerne des derives de pyrazinone substitues selon la formule generale (I), un sel d'addition acide ou… Expand
Is this relevant?
2004
2004
In an effort to discover potent, clinically useful thrombin inhibitors, a rapid analogue synthetic approach was used to explore… Expand
Is this relevant?
1999
1999
Cyclization of (S,S)-alpha-[(1-phenylethyl)amino]-alpha-(2-iodophenyl)acetonitrile with (COCl)(2) in toluene or chlorobenzene… Expand
Is this relevant?
1977
1977
The requirements for maximum production of arglecin, 3-isobuty1-6-(3-guanidinopropyl)-2(1H)pyrazinone, by Streptomyces… Expand
Is this relevant?
1972
1972
 
Is this relevant?
1971
1971
A new streptomycete metabolite named arglecin was isolated from the culture filtrates of the strains KA57-AG3, KB59-M1 and the… Expand
Is this relevant?